FDA Advisory Committee Rejects Combination Vaccine
ATLANTA, Ga-An advisory committee has narrowly rejected to recommend a combination vaccine for children after questioning the vaccination's immunogenicity.
Infanrix, manufactured by GlaxoSmithKline, was voted down by a 6-5 vote. There was one abstention.
The vaccine is designed to guard against five common childhood diseases: diphtheria, whooping cough, tetanus, hepatitis B, and polio. The panel said the vaccine would not be recommended to the FDA because they questioned its effectiveness in creating a protective immune response.
The advisory panel's decision is not final; although, it is strongly considered by the FDA when approving new drugs.
A spokesperson for GlaxoSmithKline said the company is confident Infanrix would ultimately be approved.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
